Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Antioxidants (Basel, Switzerland)|January 28, 2026
Role of Sulfide Quinone Oxidoreductase and Supersulfides in Hepatic Ischemia-Reperfusion Injury in MiceShinnosuke Takamori, Kazuhiro Shirozu, Eizo Marutani, et al.
Redox Biology|January 19, 2023
Cysteine hydropersulfide reduces lipid peroxidation and protects against myocardial ischaemia-reperfusion injury - Are endogenous persulfides mediators of ischaemic preconditioning?Kayleigh Griffiths, Tomoaki Ida, Masanobu Morita, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Sulfide:quinone oxidoreductase drives mitochondrial supersulfide metabolism to regulate bioenergetics and longevity in eukaryotesJia Yao, Tetsuro Matsunaga, Akira Nishimura, et al.
Journal of Clinical Biochemistry and Nutrition|November 30, 2022
8-Nitro-cGMP suppresses mineralization by mouse osteoblastsKotaro Kaneko, Yoichi Miyamoto, Tomoaki Ida, et al.
RMD Open|January 2, 2023
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositisTomoaki Ida, Shunsuke Furuta, Asuka Takayama, et al.
Redox Biology|December 5, 2024
Non-thermal atmospheric pressure plasma-irradiated cysteine protects cardiac ischemia/reperfusion injury by preserving supersulfidesAkiyuki Nishimura, Tomohiro Tanaka, Kakeru Shimoda, et al.
Journal of the American Heart Association|November 8, 2015
Thiosulfate Mediates Cytoprotective Effects of Hydrogen Sulfide Against Neuronal IschemiaEizo Marutani, Marina Yamada, Tomoaki Ida, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2021
GRIM-19 is a target of mycobacterial Zn2+ metalloprotease 1 and indispensable for NLRP3 inflammasome activationTomomi Kurane, Tetsuro Matsunaga, Tomoaki Ida, et al.
Rheumatology (Oxford, England)|July 17, 2023
Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database studyTomoaki Ida, Kei Ikeda, Hiroyuki Ohbe, et al.
RMD Open|February 22, 2024
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDsShotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, et al.
Pageof 9